M&A Deal Summary

DirectMeds Acquires Autumn DNA

On June 4, 2025, DirectMeds acquired consumer services company Autumn DNA

Acquisition Highlights
  • This is DirectMeds’ 1st transaction in the Consumer Services sector.
  • This is DirectMeds’ 1st transaction in the United States.
  • This is DirectMeds’ 1st transaction in California.

M&A Deal Summary

Date 2025-06-04
Target Autumn DNA
Sector Consumer Services
Buyer(s) DirectMeds
Deal Type Add-on Acquisition

Target

Autumn DNA

San Diego, California, United States
Autumn DNA delivers personalized nutrition solutions based on an individual’s genetic profile and lifestyle factors. Through advanced algorithmic analysis, Autumn DNA empowers users with precision supplements that adapt over time for long-term health and optimization. Autumn DNA was formed in 2019 and is headquartered in San Diego, California.

Search 214,503 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

DirectMeds

United States

Category Company
Sector Consumer Services
DESCRIPTION

DirectMeds provides telehealth consultations and prescription delivery services focusing on GLP-1-based weight loss and metabolic treatments.


DEAL STATS #
Overall 1 of 1
Sector: Consumer Services M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2025 M&A 1 of 1